Business & Industry

Nimbus Therapeutics has announced that it has entered into a multi-year research partnership and a $1.3 billion exclusive license agreement with Eli Lilly in order to develop oral treatments in obesity as well as other metabolic diseases. Lilly, which very...

Sanofi and Earendil Labs have announced a strategic collaboration effort that goes on to apply the discovery platform from Earendil across many of the Sanofi autoimmune and inflammatory disease programs. The two AI-powered research and development platforms from Earendil Labs concerning protein therapeutics go on...

Insilico Medicine has gone ahead with a multi-year research and development - R&D collaboration with Servier, of almost $888m, in order to develop and discover certain new oncology therapies. The partnership combines the AI drug discovery platforms of Insilico...

Johnson & Johnson - J&J has completed the acquisition of Halda Therapeutics which is a clinical-stage biotechnology firm for an amount of $3.05bn in cash. This move goes on to bring the Regulated Induced Proximity Targeting Chimera -RIPTAC platform from Halda to...

Understanding the critical role of containment isolators, biosafety cabinets, and specialized infrastructure in protecting operators and maintaining product integrity during high-potency API manufacturing requires examining regulatory frameworks, engineering controls, and facility design principles that define modern pharmaceutical safety standards.

Temperature-sensitive biologics, advanced therapeutics, and pharmaceutical research materials demand specialized cold storage infrastructure spanning ultra-low temperature freezers, controlled-rate freezing systems, and validated stability chambers that maintain precise thermal conditions throughout research, development and testing workflows.

In the most recent of a string of announcements ahead of the holiday season, Centers for Medicare & Medicaid Services (CMS) has unveiled a new voluntary access programme which aims to widen the usage of GLP-1 agonist medicines when it...